Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

Posts tagged Lincoln Pharma

Dolly Khanna Teams Up With Kishore Bang & Motilal Oswal To Scoop Up Micro-Cap Pharma Stock



Dolly Khanna appears to have overcome her aversion to Pharma stocks. This time, instead of being a lone wolf, she has relied on the collective wisdom of Kishore Bang and Motilal Oswal to home in on a micro-cap Pharma stock with impressive past performance and ambitious future plans

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 495 other subscribers

RSS Stocks Talk Forum

  • Suraj Estate Developers has a robust project lineup & launch pipeline. TP ₹992 (+73%)
    Suraj Estate Developers has a robust project lineup & launch pipeline, leadership position in redevelopment projects, strong cost advantage, proven track record, huge addressable market and healthy Balance Sheet with predictable cash flows. TP ₹992 (+73%) Download research report... Suraj Estate Developers has a robust project lineup & launch pipeline. TP ₹992 (+73%)
  • DCX Systems has the ability to become a key player in EMS space. TP ₹466 (+54%)
    DCX Systems has the ability to become a key player in EMS space with huge potential in railway & defence. It has ability to deliver high value complicated & critical products for leading defense players L&T & Lockheed. Order book ₹3000 Cr. TP ₹466 (+54%) Download... DCX Systems has the ability to become a key […]
  • Affle has a unique business model, unmatched network effects & prudent acquisition strategy
    Affle has a unique business model, unmatched network effects & prudent acquisition strategy. It is well-positioned to capitalize on growth in digital advertising in high-potential sectors such as e-commerce, fintech, gaming & entertainment. TP ₹2538 (60%) Download research report ... Affle has a unique business model, unmatched network effects & prudent acquisition strategy
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!